Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Hetero Drugs Limited – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘Hetero Drugs Limited – Product Pipeline Review – 2015’, provides an overview of the Hetero Drugs Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Hetero Drugs Limited’s, complete with comparative analysis at various stages, therapeutics ……

Total Pages: 23

hetero-drugs-limited-product-pipeline-review-2015
600
#9e2f22

Global Markets Direct’s, ‘Hetero Drugs Limited - Product Pipeline Review - 2015’, provides an overview of the Hetero Drugs Limited’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Hetero Drugs Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Hetero Drugs Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hetero Drugs Limited’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Hetero Drugs Limited’s pipeline products

Reasons to buy

- Evaluate Hetero Drugs Limited’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hetero Drugs Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hetero Drugs Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hetero Drugs Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hetero Drugs Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hetero Drugs Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Hetero Drugs Limited Snapshot 4
Hetero Drugs Limited Overview 4
Key Information 4
Key Facts 4
Hetero Drugs Limited - Research and Development Overview 5
Key Therapeutic Areas 5
Hetero Drugs Limited - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Hetero Drugs Limited - Pipeline Products Glance 11
Hetero Drugs Limited - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Hetero Drugs Limited - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Hetero Drugs Limited - Drug Profiles 13
adalimumab biosimilar 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
bevacizumab biosimilar 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
trastuzumab biosimilar 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Hetero Drugs Limited - Pipeline Analysis 16
Hetero Drugs Limited - Pipeline Products by Target 16
Hetero Drugs Limited - Pipeline Products by Route of Administration 17
Hetero Drugs Limited - Pipeline Products by Molecule Type 18
Hetero Drugs Limited - Pipeline Products by Mechanism of Action 19
Hetero Drugs Limited - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

 

List of Tables
Hetero Drugs Limited, Key Information 4
Hetero Drugs Limited, Key Facts 4
Hetero Drugs Limited - Pipeline by Indication, 2015 6
Hetero Drugs Limited - Pipeline by Stage of Development, 2015 7
Hetero Drugs Limited - Monotherapy Products in Pipeline, 2015 8
Hetero Drugs Limited - Partnered Products in Pipeline, 2015 9
Hetero Drugs Limited - Partnered Products/ Combination Treatment Modalities, 2015 10
Hetero Drugs Limited - Phase III, 2015 11
Hetero Drugs Limited - Preclinical, 2015 12
Hetero Drugs Limited - Pipeline by Target, 2015 16
Hetero Drugs Limited - Pipeline by Route of Administration, 2015 17
Hetero Drugs Limited - Pipeline by Molecule Type, 2015 18
Hetero Drugs Limited - Pipeline Products by Mechanism of Action, 2015 19
Hetero Drugs Limited, Other Locations 20
Hetero Drugs Limited, Subsidiaries 21

 

List of Figures
Hetero Drugs Limited - Pipeline by Top 10 Indication, 2015 6
Hetero Drugs Limited - Pipeline by Stage of Development, 2015 7
Hetero Drugs Limited - Monotherapy Products in Pipeline, 2015 8
Hetero Drugs Limited - Pipeline by Top 10 Target, 2015 16
Hetero Drugs Limited - Pipeline by Top 10 Route of Administration, 2015 17
Hetero Drugs Limited - Pipeline by Top 10 Molecule Type, 2015 18
Hetero Drugs Limited - Pipeline Products by Top 10 Mechanism of Action, 2015 19


LICENSE TYPE